SCHEMBL8529757

SCHEMBL8529757

CS(=O)(=O)Nc1ccc2c(c1)C(=Cc1ccnc3ccccc13)C(=O)N2

nearest known ligand 0.58

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PDPK1 O15530 3/20 0.58
MET P08581 1/20 0.47
BRD4 O60885 2/20 0.43
CHEK1 O14757 1/20 0.43
TLK2 Q86UE8 4/20 0.42
NTRK1 P04629 2/20 0.42
SYK P43405 2/20 0.42
FCER2 P06734 1/20 0.42
NTRK3 Q16288 1/20 0.42
NTRK2 Q16620 1/20 0.42
RET P07949 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
GSK3B P49841 1/20 0.42
CYP17A1 P05093 1/20 0.41
CCNE2 O96020 1/20 0.39
CCNE1 P24864 1/20 0.39
CDK2 P24941 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7137514 0.82 SYK (0.52) PDPK1CHEK1NTRK1SYKFCER2
SCHEMBL8527884 0.82 AKT2 (0.58) PDPK1TLK2
SCHEMBL7558047 0.81 CHEK1 (0.66) PDPK1METCHEK1NTRK1SYK
SCHEMBL7558053 0.81 CHEK1 (0.66) PDPK1METCHEK1NTRK1SYK
SCHEMBL8614775 0.81 NTRK1 (0.44) PDPK1CHEK1TLK2NTRK1RET
SCHEMBL8530208 0.81 SYK (0.64) PDPK1NTRK1SYKFCER2NTRK3
SCHEMBL8527796 0.81 SYK (0.51) PDPK1CHEK1NTRK1SYKFCER2
SCHEMBL7131127 0.80 NTRK1 (0.47) CHEK1NTRK1SYKNTRK3NTRK2
SCHEMBL8529758 0.80 PDPK1 (0.52) PDPK1CHEK1NTRK1RETTDP1
SCHEMBL8508649 0.80 RPS6KA3 (0.54) PDPK1CHEK1NTRK1SYKFCER2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5840745-A INHIBITING CELL PROLIFERATION, TUMOR GROWTH, METASTASIS, DEVELOPMENT OF ATHEROMATOUS PLAQUE AND RESTENOSIS, CONTROLLING ANGIOGENESIS, TREATING DIABETES, ENHANCING CANCER THERAPY PHARMACIA S. P. A. (IT) 1998-11-24 US claimed
WO-1996022976-A1 HYDROSOLUBLE 3-ARYLIDENE-2-OXINDOLE DERIVATIVES AS TYROSINE KINASE INHIBITORS PHARMACIA S.P.A. (IT) 1996-08-01 WO claimed
US-5840745-A INHIBITING CELL PROLIFERATION, TUMOR GROWTH, METASTASIS, DEVELOPMENT OF ATHEROMATOUS PLAQUE AND RESTENOSIS, CONTROLLING ANGIOGENESIS, TREATING DIABETES, ENHANCING CANCER THERAPY PHARMACIA S. P. A. (IT) 1998-11-24 US disclosed
EP-0752985-A1 HYDROSOLUBLE 3-ARYLIDENE-2-OXINDOLE DERIVATIVES AS TYROSINE KINASE INHIBITORS PHARMACIA & UPJOHN S.p.A. (IT) 1997-01-15 EP disclosed
WO-1996022976-A1 HYDROSOLUBLE 3-ARYLIDENE-2-OXINDOLE DERIVATIVES AS TYROSINE KINASE INHIBITORS PHARMACIA S.P.A. (IT) 1996-08-01 WO disclosed